Louisiana 2022 2022 Regular Session

Louisiana Senate Bill SB60 Comm Sub / Analysis

                    The original instrument and the following digest, which constitutes no part of the
legislative instrument, were prepared by Brandi Cannon.
DIGEST
SB 60 Original	2022 Regular Session	Cathey
Proposed law provides that a physician who attends a pregnant woman during labor or delivery shall
take or have taken a sample of her blood within eight hours after delivery to identify the presence
of any controlled dangerous substance. Proposed law requires, in the case of a positive test result,
for the healthcare facility where the birth occurred to provide the mother with information for
improving her own health and the health of her baby, including referrals to appropriate resources for
health screenings, behavioral health services, and substance use and recovery services. 
Proposed law provides for a limit on the use of a positive test result obtained solely pursuant to
proposed law, unless the woman has obstetrical complications that are a medical indication of
possible use of a controlled substance for a nonmedical purpose.
Proposed law provides for the La. Dept. of Health and the Dept. of Children and Family Services to
work jointly to develop the information necessary for healthcare facilities to implement the
provisions of proposed law. 
Effective August 1, 2022.
(Adds R.S. 40:1121.25)